AEM vs NGD

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

NGD presents a high-growth profile with a stable Piotroski F-Score of 4/9 and a current price ($9.08) trading very close to its growth-based intrinsic value ($9.44). While the Graham Number ($3.36) suggests a defensive undervaluation gap, the stock's massive earnings growth (275% YoY) and a highly attractive Forward P/E of 7.69 justify the current premium. Despite strong profitability and low debt/equity, short-term liquidity is a concern with a current ratio of 0.88. The overall outlook is bullish based on fundamental expansion, though technicals remain bearish in the short term.